DSCSA compliance in a supply chain is achievable with the combined efforts of all the participants- the manufacturers, the wholesale distributor or the warehouse manager, and the dispenser. While each of them has to maintain compliant standards by deploying software and traceability solutions, manufacturers specifically have to ensure that they…

Transforming the drug supply chain has been a continuous process since 2013 when the DSCSA, popularly known as the drug supply chain act came into being. …

Interoperability, the term which currently reigning the pharma supply chain, is shrouded by an air of mysticism even since the United States realized the need for some sort of a serial code or a bar code to authenticate products in a supply chain. …

The rising prices of drugs is the second largest concern of the end-users after the disease itself. A short-term prescription course can charge you anywhere between $100 to $1200 per year. Long term and terminal diseases like Cancer may need medicines of up to $10,000 every month. …

Serialization has come a long way from just labelling packages with serial numbers. While the deadline for serialization compliance is already over, supply chain stakeholders are yet to cover milestones pertaining to it that await them in the future. Serialization has come to mean a lot more to the stakeholders…

A pharma supply chain is a global affair, especially in modern times. The raw materials can be processed and packaged in a different country, sent for manufacturing in a developed region and then sent back to developing countries like Africa for repackaging or distribution. Drugs change hands several times before…

DSCSA compliance has been a blessing for the drug supply chain in the USA because the country is the largest consumer of prescription drugs in the world. According to a survey by the Centers for Disease Control and Prevention, in the year 2015–2016, 45.8% of the US population used prescription…

Enough has been said about the importance of serialization in eliminating the counterfeit drug from the pharmaceutical supply chain, but the way it functions is yet to be decoded. …

As the deadline for VRS compliance on 27th November approaches, pharmaceutical warehouses are increasingly concerned about their compliance status and whether or not they would qualify the VRS audit that takes into account everything from the equipment that is being used to perform verification of saleable returns to the methodology…